Q4 2011

Filed Aug 29, 2011 · 10-K · 90 days after period end · 0001019687-11-002842

Q4 2011 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net Income

-$2.37M

derivedno prior Q4 2010 on file

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$799,907—

Same quarter

no prior Q4 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended May 31, 2011 · filed Aug 29, 2011 · 90 d after period end

Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR